Quadrise Fuels Intnl - Update on bioMSAR™ Testing
Quadrise Fuels International plc
("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")
Update on bioMSAR™ Testing
Quadrise, the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, which are low-cost, cleaner alternatives to heavy fuel oil and biofuels, is pleased to provide an update on the testing of bioMSAR™ on a medium speed 4-stroke Wärtsilä diesel engine at the VTT facility in
bioMSAR™ Testing at VTT
A comprehensive suite of tests has been completed on a Wärtsilä 4-stroke engine using 5mt of bioMSAR™ fuel produced at QRF. This engine was the same generic type previously used for MSAR® testing, though it has since been modified for dual fuel operation, and this required further work to enable comparison with the earlier MSAR® test results.
The final bioMSAR™ test results show the following versus conventional liquid fuels:
· Greater than expected calculated CO2 savings - with reductions of 26-28%.
· Engine efficiency increased by up to 7%.
· Highly efficient combustion evidenced by low NOx, CO, particulate and soot emissions.
The CO2 savings delivered by existing biofuels are more typically in the region of 10-15%. bioMSARTM 's formulation can be adjusted to provide the consumers' required CO2 savings at the lowest cost.
The results of the test have been shared with MSC and an update on the MSC trial programme will be provided, as appropriate, in due course.
Further Testing at Aquafuel
Following the successful initial tests reported in
These modifications are now complete and the further bioMSAR™ testing to optimise emissions and engine performance will be carried out at Aquafuel, commencing later this month. Quadrise will be attending the tests at the Aquafuel site and some of this work will be included in the final segment of filming for Quadrise's contribution to the
We expect the results of further testing at Aquafuel to be available by the end of September.
"We are very pleased to share the positive bioMSAR™ test results - especially those relating to CO2 reductions and higher efficiencies. Quadrise is making great progress on bioMSAR™ testing and development. This work is crucial in enabling Quadrise to offer customers a lower cost renewable fuel solution, alongside our existing MSAR® fuel, and we look forward to sharing further information with shareholders during Q3 2021.
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the
For further information, please contact:
|
Quadrise Fuels International Plc |
|
|
|
+44 (0)20 7031 7321 |
|
|
|
|
|
|
|
Nominated Adviser |
|
|
Cenkos Securities plc |
|
|
|
+44 (0)20 7397 8900 |
|
|
|
|
Joint Brokers |
|
|
Peel Hunt LLP |
|
|
|
+44 (0)20 7418 8900 |
|
|
|
|
|
|
|
Shore Capital Stockbrokers Limited |
|
|
|
+44 (0)20 7408 4090
|
|
Public & Investor Relations |
|
|
FTI Consulting |
|
|
|
+44 (0)20 3727 1000 |
|
Ntobeko Chidavaenzi |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
This content is published by Proactive Investors Limited and made available subject to the terms and conditions of use of its website (see Terms of Use).
Proactive Investors is a full-service financial newswire. We produce independent, objective financial journalism and do not provide personalised investment advice, act as a broker, or recommend specific securities to individual investors.
Financial content published on this Site is produced under the journalist exemption provided for in Article 20 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, and in accordance with FCA guidance at PERG 8.12. Where a communication is not otherwise exempt, it is issued or approved for distribution in the UK by Proactive Investors Limited.
All information used in the preparation of this communication has been compiled from publicly available sources that we believe to be reliable, however, we cannot, and do not, guarantee the accuracy or completeness of this communication.
This communication is intended for information purposes only and does not constitute investment advice, a personal recommendation, an offer, solicitation, or inducement to buy or sell any investment or financial product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
This communication has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Before entering into any transaction, investors should consider suitability for their individual circumstances and should read the relevant prospectus, term sheet, subscription agreement, information memorandum, prospectus or other offering document in full.
Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise, and you may not recover the amount you invest.
This communication may contain information obtained from third parties, including credit ratings and financial data. Reproduction and distribution of third-party content in any form is prohibited except with the prior written consent of the relevant third party. Credit ratings are statements of opinion and should not be relied upon as investment advice.
FOR OUR FULL DISCLAIMER CLICK HERE